Dana Goldman
Goldman, Dana P.
Goldman, Dana P. (Dana Paul), 1966-
Goldman, Dana P. 1966-
Goldman, Dana
Goldman, Dana Paul, 1966-....
VIAF ID: 10782328 ( Personal )
Permalink: http://viaf.org/viaf/10782328
Preferred Forms
- 100 0 _ ‡a Dana Goldman
- 100 0 _ ‡a Dana Goldman
-
-
-
- 100 1 _ ‡a Goldman, Dana P. ‡d 1966-
- 100 1 _ ‡a Goldman, Dana P. ‡q (Dana Paul), ‡d 1966-
- 100 1 _ ‡a Goldman, Dana Paul, ‡d 1966-....
4xx's: Alternate Name Forms (7)
5xx's: Related Names (9)
- 510 2 _ ‡a Leonard D. Schaeffer Center for Health Policy and Economics ‡4 affi ‡4 http://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
- 510 2 _ ‡a National Bureau of Economic Research
- 510 2 _ ‡a National Bureau of Economic Research ‡4 affi ‡4 http://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
- 510 2 _ ‡a Rand Corporation
- 510 2 _ ‡a Rand Corporation ‡4 affi ‡4 http://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
- 510 2 _ ‡a Stanford University
- 510 2 _ ‡a University of California Berkeley ‡4 affi ‡4 http://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
- 510 2 _ ‡a University of Southern California
- 510 2 _ ‡a University of Southern California ‡4 affi ‡4 http://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
Works
Title | Sources |
---|---|
Are the young becoming more disabled? | |
Comparing medical productivity between Germany and the US an assessment of differences and trends in costs, treatments and outcomes for acute myocardial infarction and colorectal cancer | |
The cost of cancer treatment study's design and methods | |
Criminal prosecution and HIV-related risky behavior | |
Economic dimensions of personalized and precision medicine | |
The effects of product liability exemption in the presence of the FDA | |
The effects of relative food prices on obesity - evidence from China 1991-2006 | |
Evaluation of the CHAMPUS reform initiative, 1993- : | |
Food prices and the dynamics of body weight | |
Health status and medical treatment of the future elderly : final report | |
Heterogeneity in Cost-Sharing and Cost-Sensitivity, and the Role of the Prescribing Physician | |
HIV breakthroughs and risky sexual behavior | |
Hospitals as hotels: the role of patient amenities in hospital demand | |
How costly is hospital quality? a revealed-preference approach | |
The impact of air quality on hospital spending | |
Integrated insurance design in the presence of multiple medical technologies | |
International differences in longevity and health and their economic consequences | |
The link between public and private insurance and HIV-related mortality | |
Market evidence of misperceived prices and mistaken mortality risks | |
Medical expenditure risk and household portfolio choice, c2005: | |
Patterns of enlisted compensation | |
Prescription drug coverage and elderly Medicare spending | |
Price variation in markets with homogeneous goods: the case of Medigap | |
The reallocation of compensation in response to health insurance premium increases | |
Socioeconomic differences in the adoption of new medical technologies | |
Understanding health disparities across education groups | |
Understanding the economic consequences of shifting trends in population health | |
Wage and benefit changes in response to rising health insurance costs |